Teachers Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Teachers Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$17.9M	Buy	255,034 +39,027	+18%	+$2.89M	0.02%	716
2018 Q4	$13.9M	Buy	216,007 +2,188	+1%	+$153K	0.02%	765
2018 Q3	$15M	Buy	213,819 +156,086	+270%	+$9.13M	0.02%	868
2018 Q2	$2.91M	Buy	57,733 +18,223	+46%	+$723K	﹤0.01%	1724
2018 Q1	$1.24M	Hold	39,510	–	–	﹤0.01%	2118
2017 Q4	$1.35M	Buy	39,510 +4,333	+12%	+$138K	﹤0.01%	2075
2017 Q3	$1.13M	Hold	35,177	–	–	﹤0.01%	2163
2017 Q2	$1.15M	Buy	35,177 +3,376	+11%	+$107K	﹤0.01%	2152
2017 Q1	$1M	Hold	31,801	–	–	﹤0.01%	2186
2016 Q4	$935K	Buy	31,801 +1,838	+6%	+$56K	﹤0.01%	2216
2016 Q3	$867K	Buy	29,963 +119	+0.4%	+$3.32K	﹤0.01%	2165
2016 Q2	$773K	Buy	29,844 +3,801	+15%	+$101K	﹤0.01%	2179
2016 Q1	$645K	Hold	26,043	–	–	﹤0.01%	2206
2015 Q4	$917K	Sell	26,043 -1,376	-5%	-$36.9K	﹤0.01%	2056
2015 Q3	$580K	Buy	27,419 +2,138	+8%	+$55.1K	﹤0.01%	2298
2015 Q2	$703K	Sell	25,281 -107,000	-81%	-$3.02M	﹤0.01%	2320
2015 Q1	$4.04M	Buy	132,281 +9,120	+7%	+$290K	0.01%	1251
2014 Q4	$3.94M	Buy	123,161 +8,200	+7%	+$267K	0.01%	1234
2014 Q3	$3.25M	Hold	114,961	–	–	0.01%	1307
2014 Q2	$3.15M	Sell	114,961 -1,446	-1%	-$38.5K	0.01%	1338
2014 Q1	$3.07M	Sell	116,407 -134,390	-54%	-$3.86M	0.01%	1329
2013 Q4	$7.34M	Buy	250,797 +36,700	+17%	+$1.16M	0.02%	948
2013 Q3	$6.55M	Buy	214,097 +1,738	+0.8%	+$58.1K	0.02%	941
2013 Q2	$6.73M	Buy	+212,359	New	+$6.97M	0.02%	894

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teachers Advisors's GHDX Position: Q1 2019 in Review

Teachers Advisors increased its Genomic Health, Inc. (GHDX) stake by 18% in Q1 2019, buying an estimated $2.89M and bringing the position to 255,034 shares worth $17.9M. The position accounts for 0.02% of the portfolio, ranked #716.

Teachers Advisors first reported a position in GHDX in Q2 2013 and has held it in 24 quarters since. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

Teachers Advisors held 255,034 shares of Genomic Health, Inc. worth $17.9M as of Q1 2019.
Teachers Advisors bought 39,027 Genomic Health, Inc. shares in Q1 2019, an estimated $2.89M.
Genomic Health, Inc. made up 0.02% of Teachers Advisors's portfolio in Q1 2019, its #716 holding.
Teachers Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 24 quarters since.
267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.